V-PLEX SARS-CoV-2 Panel 13 and 14 (IgG) Kits

Notice ID:

NOI-NIAID-2105227

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

NATIONAL INSTITUTES OF HEALTH NIAID

Office:

NATIONAL INSTITUTES OF HEALTH NIAID

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

(utc-05:00) eastern standard time, new york, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

dec 27, 2021 12:00 pm est

Inactive Policy:

15 days after response date

Product Service Code:

6505 - drugs and biologicals

NAICS Code:

325413 - in-vitro diagnostic substance manufacturing

Original Set Aside:

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Meso Scale Discovery will provide the V-PLEX SARS-CoV-2 Panel 13 and 14 (IgG) Kits. The National Institute of Allergy and Infectious Diseases (NIAID) has an urgent requirement for the V-PLEX SARS-CoV-2 Panel 13 and 14 kits for use in the COVID-19 research. As the threat of COVID-19 continues in the international community with new variants emerging every week, the need for a safe and efficacious monoclonal antibody therapy at an accelerated timeline is a health care priority. To assist in this effort, the VRC-VIP will use the electrochemiluminescent (ECL) assay format which they have recently developed for a SARS CoV-2 specific assay for the detection of specific antibodies directed towards SARS CoV-2 S-2P (or other stabilized version of this same protein), SARS CoV-2 Receptor Binding Domain (RBD) and SARS CoV-2 N ( nucleocapsid proteins), SARS-CoV-2 NTD, SARS CoV-2 S1, SARS CoV-2 S2, and variant spikes (P.1, B.1.1.7, B.1.351, B.1.526.1, A.23.1, A.VOI.V2, B.1.617.2, C.37, R.1, P.3, B.1.525, B.1.1.519, BV-1). The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2105227 to Maliaka Pinkney at maliaka.pinkney@nih.gov, by 12:00 pm eastern standard time Tuesday, December 27, 2021. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

5601 FISHERS LANE, SUITE 3D11

BETHESDA , MD 20892

USA

Primary Point of Contacts:

Maliaka Pinkney

Secondary Point of Contact:

Julienne Keiser